Apex Healthcare Berhad (KLSE:AHEALTH)

Apex Healthcare Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	952.47	961.78	936.17	877.74	770.76	698.73
Revenue Growth (YoY)	1.48%	2.74%	6.66%	13.88%	10.31%	1.44%
Cost of Revenue	727.07	736.18	721.34	680.15	609.78	550.51
Gross Profit	225.4	225.59	214.83	197.59	160.97	148.22
Selling, General & Admin	127.31	128.26	123.86	112	98.08	93.29
Other Operating Expenses	-6.86	-6.78	12.2	-2.14	-2.77	-4.75
Operating Expenses	120.45	121.47	136.06	109.87	95.31	88.54
Operating Income	104.95	104.12	78.77	87.73	65.66	59.67
Interest Expense	-1.83	-1.4	-0.56	-0.76	-0.86	-1.15
Interest & Investment Income	7.81	7.81	6.86	1.62	1.82	1.79
Earnings From Equity Investments	-10.82	-9.78	336.4	29.57	7.1	8.66
Currency Exchange Gain (Loss)	0.25	0.25	1.55	1.51	1.25	0.99
EBT Excluding Unusual Items	97.39	100.99	423.02	119.66	74.96	69.97
Gain (Loss) on Sale of Assets	0.2	0.2	0.28	0.69	0.18	0.18
Pretax Income	97.6	101.2	423.31	120.36	75.41	70.17
Income Tax Expense	24.68	24.66	25.32	19.38	15.98	14.16
Earnings From Continuing Operations	72.92	76.54	397.99	100.97	59.44	56.01
Minority Interest in Earnings	-	-	-	0	-0.02	0.01
Net Income	72.92	76.54	397.99	100.97	59.42	56.02
Net Income to Common	72.92	76.54	397.99	100.97	59.42	56.02
Net Income Growth	-81.53%	-80.77%	294.15%	69.94%	6.06%	6.20%
Shares Outstanding (Basic)	715	715	714	711	710	710
Shares Outstanding (Diluted)	715	715	715	714	711	712
Shares Change (YoY)	0.05%	0.09%	0.16%	0.33%	-0.14%	0.34%
EPS (Basic)	0.10	0.11	0.56	0.14	0.08	0.08
EPS (Diluted)	0.10	0.11	0.56	0.14	0.08	0.08
EPS Growth	-81.54%	-80.78%	293.50%	69.46%	6.10%	5.92%
Free Cash Flow	56.36	41.03	39.26	41.76	50.85	69.66
Free Cash Flow Per Share	0.08	0.06	0.06	0.06	0.07	0.10
Dividend Per Share	0.090	0.090	0.050	0.043	0.037	0.030
Dividend Growth	80.00%	80.00%	15.47%	17.98%	22.33%	21.46%
Gross Margin	23.66%	23.46%	22.95%	22.51%	20.89%	21.21%
Operating Margin	11.02%	10.83%	8.41%	9.99%	8.52%	8.54%
Profit Margin	7.66%	7.96%	42.51%	11.50%	7.71%	8.02%
Free Cash Flow Margin	5.92%	4.27%	4.19%	4.76%	6.60%	9.97%
EBITDA	124.54	123.09	95.47	103.03	80.8	74.88
EBITDA Margin	13.08%	12.80%	10.20%	11.74%	10.48%	10.72%
D&A For EBITDA	19.59	18.97	16.69	15.31	15.14	15.21
EBIT	104.95	104.12	78.77	87.73	65.66	59.67
EBIT Margin	11.02%	10.83%	8.41%	9.99%	8.52%	8.54%
Effective Tax Rate	25.29%	24.36%	5.98%	16.11%	21.18%	20.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.